QQQ   427.26 (+0.33%)
AAPL   168.06 (+0.04%)
MSFT   409.46 (-0.58%)
META   509.21 (+3.04%)
GOOGL   155.95 (+0.31%)
AMZN   182.05 (+0.42%)
TSLA   151.60 (-2.48%)
NVDA   852.39 (+1.43%)
AMD   156.16 (+1.39%)
NIO   4.04 (+3.32%)
BABA   69.50 (+0.99%)
T   16.19 (+0.43%)
F   12.17 (+1.08%)
MU   116.27 (-0.05%)
GE   157.58 (+1.23%)
CGC   7.39 (+13.87%)
DIS   113.92 (+0.87%)
AMC   2.88 (-3.36%)
PFE   25.43 (+0.04%)
PYPL   63.16 (-0.16%)
XOM   119.02 (+0.33%)
QQQ   427.26 (+0.33%)
AAPL   168.06 (+0.04%)
MSFT   409.46 (-0.58%)
META   509.21 (+3.04%)
GOOGL   155.95 (+0.31%)
AMZN   182.05 (+0.42%)
TSLA   151.60 (-2.48%)
NVDA   852.39 (+1.43%)
AMD   156.16 (+1.39%)
NIO   4.04 (+3.32%)
BABA   69.50 (+0.99%)
T   16.19 (+0.43%)
F   12.17 (+1.08%)
MU   116.27 (-0.05%)
GE   157.58 (+1.23%)
CGC   7.39 (+13.87%)
DIS   113.92 (+0.87%)
AMC   2.88 (-3.36%)
PFE   25.43 (+0.04%)
PYPL   63.16 (-0.16%)
XOM   119.02 (+0.33%)
QQQ   427.26 (+0.33%)
AAPL   168.06 (+0.04%)
MSFT   409.46 (-0.58%)
META   509.21 (+3.04%)
GOOGL   155.95 (+0.31%)
AMZN   182.05 (+0.42%)
TSLA   151.60 (-2.48%)
NVDA   852.39 (+1.43%)
AMD   156.16 (+1.39%)
NIO   4.04 (+3.32%)
BABA   69.50 (+0.99%)
T   16.19 (+0.43%)
F   12.17 (+1.08%)
MU   116.27 (-0.05%)
GE   157.58 (+1.23%)
CGC   7.39 (+13.87%)
DIS   113.92 (+0.87%)
AMC   2.88 (-3.36%)
PFE   25.43 (+0.04%)
PYPL   63.16 (-0.16%)
XOM   119.02 (+0.33%)
QQQ   427.26 (+0.33%)
AAPL   168.06 (+0.04%)
MSFT   409.46 (-0.58%)
META   509.21 (+3.04%)
GOOGL   155.95 (+0.31%)
AMZN   182.05 (+0.42%)
TSLA   151.60 (-2.48%)
NVDA   852.39 (+1.43%)
AMD   156.16 (+1.39%)
NIO   4.04 (+3.32%)
BABA   69.50 (+0.99%)
T   16.19 (+0.43%)
F   12.17 (+1.08%)
MU   116.27 (-0.05%)
GE   157.58 (+1.23%)
CGC   7.39 (+13.87%)
DIS   113.92 (+0.87%)
AMC   2.88 (-3.36%)
PFE   25.43 (+0.04%)
PYPL   63.16 (-0.16%)
XOM   119.02 (+0.33%)
Free Trial

CorMedix (CRMD) Stock Forecast & Price Target

→ IRS Loophole Gives Americans An Escape From Inflation (From Birch Gold) (Ad)
Free CRMD Stock Alerts
$5.63
+0.19 (+3.49%)
(As of 10:57 AM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

CorMedix Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Buy
Based on 4 Analyst Ratings

Analysts' Consensus Price Target

$13.00
130.91% Upside
High Forecast$19.00
Average Forecast$13.00
Low Forecast$9.00
TypeCurrent Forecast
4/19/23 to 4/18/24		1 Month Ago
3/20/23 to 3/19/24		3 Months Ago
1/19/23 to 1/19/24		1 Year Ago
4/19/22 to 4/19/23
Consensus Rating
Buy
Buy
Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
4 Buy rating(s)
4 Buy rating(s)
3 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$13.00$13.00$14.25$15.00
Predicted Upside130.91% Upside286.90% Upside369.14% Upside266.75% Upside
Get CorMedix Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CRMD and its competitors with MarketBeat's FREE daily newsletter.

CRMD Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CRMD Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

CorMedix Stock vs. The Competition

TypeCorMedixMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.68
2.49
Consensus RatingBuyModerate BuyHold
Predicted Upside130.91% Upside940.51% Upside12.24% Upside
News Sentiment RatingPositive News
Neutral News
Positive News

Recent Analyst Ratings and Stock Forecasts

Export to Excel
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
4/9/2024JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingMarket Outperform ➝ Market Outperform$19.00+299.16%
4/9/2024Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Reiterated RatingBuy ➝ Buy$10.00+110.08%
3/13/2024Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetOutperform ➝ Outperform$10.00 ➝ $9.00+134.99%
1/31/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating		 Lower TargetBuy ➝ Buy$18.00 ➝ $14.00+360.53%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 11:14 AM ET.

CRMD Price Target - Frequently Asked Questions

What is CorMedix's consensus rating and price target?

According to the issued ratings of 4 analysts in the last year, the consensus rating for CorMedix stock is Buy based on the current 4 buy ratings for CRMD. The average twelve-month price prediction for CorMedix is $13.00 with a high price target of $19.00 and a low price target of $9.00. Learn more on CRMD's analyst rating history.

Do Wall Street analysts like CorMedix more than its competitors?

Analysts like CorMedix more than other Medical companies. The consensus rating for CorMedix is Buy while the average consensus rating for medical companies is Moderate Buy. Learn more on how CRMD compares to other companies.

Does CorMedix's stock price have much upside?

According to analysts, CorMedix's stock has a predicted upside of 217.27% based on their 12-month stock forecasts.

What analysts cover CorMedix?

CorMedix has been rated by JMP Securities, Needham & Company LLC, Royal Bank of Canada, and Truist Financial in the past 90 days.


Stock Ratings Reports and Tools

Related Companies:
Today's Ratings:
Top Rated Stocks:
More Ratings Tools:
This page (NASDAQ:CRMD) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
He Is Giving Away Bitcoin
Crypto Swap Profits
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
IRS Loophole Gives Americans An Escape From Inflation
Birch Gold
The “Perfect Storm” for Gold
Gold Safe Exchange
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
Rich Dad Poor Dad Author Shocks Millions With 2024 Crash Warning
American Hartford Gold Group